SYNTHESIS OF IBB
1 H and 13 C NMR spectra were acquired with a Bruker DPX-300 or AV-400 instrument (Bruker Instruments, Billerica, MA) . All reactions were carried out under argon. Anhydrous THF, DMF and Et 3 N were either commercial available or dried under in house solvent purification system. Purification by column chromatography was carried out on silica gel and TLC plates were visualized by UV and stained with phosphomolybdic acid. Compounds 2, 3 and 4 were prepared according to reported procedures. {Rock, 1996 #34} 3-(tert-butyldimethylsilyloxy)benzaldehyde (2). To a solution of 3-hydroxylbenzaldehyde (6.1 g, 50 mmol) in THF (150 mL) was added tert-butyldimethylsilyl chloride (TBDMSCl, 9.0 g, 60 mmol). The solution was cooled to 0 o C and triethylamine (8.3 mL, 60 mmol) was added dropwise. A precipitate formed immediately. After stirring overnight, the reaction mixture was filtered and the THF removed under reduced pressure. The crude product was purified by silica gel chromatography (eluent hexane-EtOAc 9:1), affording 2 as a slightly yellow oil (10.1 g, 86%). 1 H-NMR (300 MHz, CD 3 Cl) δ 0.24 (s, 6H), 1.02(s, 9H), 7. 10-7.16 (m, 1H), 7.28-7.53 (m, 3H), 9.98 (s, 1H) ; 13 C NMR (75 MHz, CD 3 Cl) δ -4. 50, 18.14, 25.55, 119.81, 123.51, 126.50, 130.02, 137.86, 156.35, 192 .08.
1-Hydroxy-1-[3-(tert-butyldimethylsilyloxy)phenyl](2-phenyl-1,3-dithian-2-yl)ethane
(3). To a solution of 2-phenyl-1,3-dithiane ( 7.84g, 40 mmol) in THF (100 mL) at 0 o C under an argon atmosphere was added 16 mL of n-butyllithium (2.5 M in hexane, 40 mmol) dropwise.
After 30 min, 2 (9.44g, 40 mmol) was added. The solution was stirred at 0 o C for 1 h, and then quenched by 6N HCl (10 mL). After evaporating the organic solvent, the residue was dissolved in 200 mL CH 2 Cl 2 and washed with brine (2 x 100 mL). The organic phase was dried with NaSO 4 and evaporated under reduced pressure. The resulting oil was crystallized from ethanol/water, affording 3 as white powder (15.7g, 91%). 1 H-NMR (300 MHz, CD 3 Cl) δ 0.13 (s, 1H), 0.96 (s, 1H), 1.88-2.00 (2H), 2.61-2.81 (4H), 2.92 (d, 1H, J = 3.8 Hz), 4.96 (d, 1H, J = 3.6 Hz), 6.39-6.48 (2H), 6.66-6.73 (1H), 6.98 (t, 1H, J = 7.8 Hz), 7.23-7.37 (3H), 7.68-7.77 (2H); 13 C NMR (75 MHz, CD 3 Cl) δ -4. 42, 18.07, 24.73, 25.63, 26.96, 27.26, 66.43, 80.87, 119.71, 119.93, 121.17, 127.49, 127.81, 128.12, 130.46, 137.37, 138.72, 154.54 . 3.2 Hz), 6.33 (s, 1H), 6.58 (d, 1H, J = 7.6 Hz), 6.82 (dd, 1H, J = 8.2 and 2.6 Hz), 7.07 (t, 1H, J = 7.8 Hz), 7.26-7.37 (3H), 7.66-7.74 (2H); 13 C NMR (75 MHz, CD 3 Cl) δ 24. 66, 26.91, 27.21, 52.10, 65.12, 80.55, 113.63, 115.25, 121.75, 127.47, 127.93, 128.06, 130.46, 137.36, 138.99, 156.54, 169.22 .
N-[2-(2-(2-aminoethoxy)ethoxy)ethyl]-2-[3-(hydroxy(2-phenyl-1,3-dithian-2yl)methyl)phenoxy]acetamide (5).
To a solution of 4 (3.9g, 10 mmol) in 400 mL methanol was added 2,2'-(Ethylenedioxy)bisethylamine (5.9 g, 40 mmol. The solution was stirred overnight, and then the organic solvent was evaporated. The crude product was purified by silica gel chromatography (eluent CH 2 Cl 2 -MeOH-NH 4 OH 50:50:1), affording 6 as a slightly yellow oil 7, 26.7, 26.8, 38.5, 40.7, 65.3, 66.7, 69.0, 69.8, 69.9, 72.1, 80.3, 114.0, 114.5, 122.0, 126.9, 127.4, 127.5, 130.9, 137.6, 140.8, 156.4, 169.6 . 7, 25.4, 26.7, 26.8, 28.1, 28.3, 35.3, 38.5, 38.9, 39.7, 55.6, 60.2, 61.9, 65.3, 66.7, 69.0, 69.2, 69.9, 80.3, 114.0, 114.5, 122.0,126.9, 127.4, 127.5, 130.9, 137.6, 140.7, 156.3, 164.6, 169.6, 174.7 . N-(2-(2-(2-(2-(3-(hydroxy(2-phenyl-1,3- 28. 02, 28.29, 29.77, 35.27, 38.44, 38.84, 39.59, 55.53, 60.14, 61.88, 66.81, 68.98, 69.14, 69.81, 75.75, 113.88, 114.20, 120.90, 128.27, 128.62, 129.74, 133.19, 134.47, 140.85, 158.00, 164.63, 169.53, 174.68, 198 .00. MS (ESI) calcd for C 32 H 43 N 4 O 8 S (MH+) 643.28, found 643.33. (2-(2-(2-(3-(1-hydroxy-2-oxo-2-phenylethyl) 
N-(2-

phenoxy)acetamido)ethoxy)ethoxy)ethyl)-5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide (8).
To a solution of 7 (320 mg, 0.5 mmol) and iodoactic acid (280 mg, 1.5 mmol) in 20 mL CH 2 Cl 2 was added DCC (270 mg, 1.3 mmol) and DMAP (6 mg, 0.05 mmol). After 2.5 h, the resulting suspension was filtered, and the filtrate was diluted with CH 2 Cl 2 . The organic phase was washed with NaHCO 3 and brine, dried with NaSO 4 . The crude product was purified by silica gel chromatography (eluent CH 2 Cl 2 -MeOH 9:1), affording 8 as a white solid (330 mg, 81%). 1 H-NMR (300 MHz, 55, 28.02, 28.20, 35.92, 38.76, 39.04, 40.46, 55.61, 60.12, 61.70, 67.60, 69.55, 69.86, 69.98, 70.05, 78.21, 115.21, 115.34, 122.22, 128.78, 130.54, 133.84, 134.15, 134.65, 157.62, 164.07, 167.93, 168.16, 173.35, 192.84 
